The Future of Clinical Trials in Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Future of Clinical Trials in Inflammatory Bowel Disease

Published:2024-07 Issue: Volume: Page:
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Ma Christopher^ORCID,Solitano Virginia,Danese Silvio,Jairath Vipul

Publisher

Elsevier BV

Reference78 articles.

1. Catching the therapeutic window of opportunity in early Crohn's disease;Danese;Curr Drug Targets,2014

2. Disease monitoring in inflammatory bowel disease: evolving principles and possibilities;Plevris;Gastroenterology,2022

3. STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD;Turner;Gastroenterology,2021

4. Selecting end points for disease-modification trials in inflammatory bowel disease: the SPIRIT consensus from the IOIBD;Le Berre;Gastroenterology,2021

5. Interpreting registrational clinical trials of biological therapies in adults with inflammatory bowel diseases;Ghosh;Inflamm Bowel Dis,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3